News
With over 800,000 customers across more than 20 countries, PhytAge Labs has carved out a reputation as a leader in ...
54m
Everyday Health on MSNZebound Beats Wegovy for Weight Loss in First Head-to-Head TrialIn a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
Whether it's drawing blood or administering medication, needles scare many people, and not everyone can imagine doing it ...
A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive ...
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
Hims research determined which fast food burgers have the healthiest nutritional content and which ones to save for a special ...
A woman who lost 55 pounds on Ozempic opens up about the most difficult side effect she faced—and shares simple tips that ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for the safe and effective redirection of nutrient absorption into ...
20h
Independent.ie on MSNNew tablet mimics gastric bypass weight-loss surgery, study findsScientists have developed a new once-a-day oral treatment for obesity that mimics metabolic effects of gastric bypass without surgery. The first in-human study of a once-daily oral treatment for ...
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results